Losoxantrone
| Losoxantrone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Overview[edit]
Losoxantrone is a synthetic antineoplastic agent belonging to the class of anthrapyrazoles. It is primarily used in the treatment of various types of cancer, including breast cancer, leukemia, and lymphoma. Losoxantrone functions by intercalating into DNA, thereby disrupting the replication of cancer cells and inhibiting their proliferation.
Mechanism of Action[edit]
Losoxantrone exerts its effects by intercalating into the DNA double helix. This intercalation disrupts the DNA replication process, leading to the inhibition of topoisomerase II, an enzyme crucial for DNA repair and replication. By inhibiting this enzyme, Losoxantrone prevents the cancer cells from dividing and proliferating, ultimately leading to cell death.
Pharmacokinetics[edit]
Losoxantrone is administered intravenously and is known for its rapid distribution throughout the body. It is metabolized primarily in the liver and excreted through the biliary system. The drug has a relatively long half-life, allowing for sustained action against cancer cells.
Clinical Use[edit]
Losoxantrone is used in the treatment of various malignancies, including:
The drug is often used in combination with other chemotherapeutic agents to enhance its efficacy.
Side Effects[edit]
Common side effects of Losoxantrone include:
- Nausea and vomiting
- Myelosuppression, leading to decreased white blood cell count
- Cardiotoxicity, which may manifest as congestive heart failure
- Alopecia
Patients receiving Losoxantrone require regular monitoring of their cardiac function and blood cell counts to manage these side effects effectively.
Research and Development[edit]
Ongoing research is focused on improving the efficacy and safety profile of Losoxantrone. Studies are exploring its use in combination with novel agents and its potential role in treating other types of cancer.
